Fidelity MSCI Health Care Index ETF
$81.64−0.86 (−1.05%)
- Expense ratio
- 0.08%
- Fund size
- $3.5B
- 1Y return
- +27.3%
- Yield · Last 12 months
- 1.23%
- Holdings
- 365
- Volume · 30D
- 0.2M sh
- NAV per share
- $81.92
- 52W range
The ETF.net FHLC Grade
Score 84 of 100 sits in the A band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.AScore 98Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.AScore 82Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.AScore 80Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.AScore 83Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.BScore 55Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 77Category rank
Our read on FHLC
AHealth care, whole market. FHLC tracks an MSCI index that runs from mega-cap pharma down to small-cap biotech and device makers, roughly 400 names, for 0.08% a year.
The fund seeks to track the performance of the MSCI USA IMI Health Care Index before fees and expenses.
Why people hold it
- Charges 0.08% a year against a 0.50% median for broad health care ETFs. Only XLV matches that sticker; VHT sits a hair above.
- The IMI index it follows reaches for about 99% of US free-float market value, so smaller biotech and device names ride along with the pharma giants.msci.com
- Mirrors its benchmark closely, one of the tighter tracking jobs among broad health care funds. Distributions come quarterly.
- Fidelity has run it since 2013, and it has grown into a multi-billion-dollar fund with a plain vanilla index mandate.institutional.fidelity.com
Worth knowing
- One sector, one country. Drug-pricing politics, patent cliffs and FDA rulings move the whole portfolio at once.
- Free-float cap weighting means a handful of mega-cap insurers and drugmakers carry most of the weight; that long tail of small names counts for less than it looks.msci.com
- Moderately traded rather than the category's volume leader, so spreads matter more on large or hurried orders.
FHLC Holdings
- Stocks
- 365
- 52%
- LLY
Sectors
- Health Care99.4%
- Technology0.6%
- Financials0.0%
Geography
- United States97.38%
- Ireland1.98%
- Bermuda0.29%
- Switzerland0.10%
- United Kingdom0.10%
- Canada0.10%
- Netherlands0.05%
FHLC Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
FHLC$12,727
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | FHLC |
|---|---|
| Year to date | +12.2% |
| 1 month | −2.2% |
| 3 months | +13.6% |
| 1 year | +27.3% |
| 3 years | +12.1% |
| 5 years | +6.1% |
| 10 years | +10.6% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | FHLC |
|---|---|---|
| 2026 YTD | +12.2% | |
| 2025 | +15.4% | |
| 2024 | +2.5% | |
| 2023 | +2.6% | |
| 2022 | −5.5% | |
| 2021 | +20.4% | |
| 2020 | +18.2% |
FHLC in the news
FHLC Dividends
- 1.23%
- $1.02
- $0.25 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Sep 18, 2026 | Sep 22, 2026 | $0.25 |
| Jun 18, 2026 | Jun 23, 2026 | $0.26 |
| Mar 20, 2026 | Mar 24, 2026 | $0.23 |
| Dec 19, 2025 | Dec 23, 2025 | $0.27 |
| Sep 19, 2025 | Sep 23, 2025 | $0.26 |
| Jun 20, 2025 | Jun 24, 2025 | $0.26 |
| Mar 21, 2025 | Mar 25, 2025 | $0.25 |
| Dec 20, 2024 | Dec 24, 2024 | $0.26 |
| Sep 20, 2024 | Sep 24, 2024 | $0.25 |
| Jun 21, 2024 | Jun 25, 2024 | $0.24 |
| Mar 15, 2024 | Mar 20, 2024 | $0.24 |
| Dec 15, 2023 | Dec 20, 2023 | $0.22 |
FHLC Risk
- 14.4%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.49
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −17.7%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.60
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
FHLC Cost
0.08%
FHLC0.08%
- The middle half of Health Care (Broad) funds
- Median 0.50%
No Health Care (Broad) fund charges less.